Compare Alcon AG (ALC) vs iShares China Large-Cap ETF (FXI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alcon AG vs iShares China Large-Cap ETF — how do they compare? Alcon AG trades at $72.57 (market cap $36.44B), while iShares China Large-Cap ETF trades at $35.42. The key difference: Alcon AG pays a 0.48% dividend while iShares China Large-Cap ETF pays none. Which is the better fit depends on your goals.
| ALC | FXI | |
|---|---|---|
Market Cap | $36.44B | — |
Sector | Health | — |
52-Week High | $90.12 | $41.75 |
52-Week Low | $62.02 | $31.59 |
Enterprise Value | $40.28B | — |
Dividend Yield | 0.48% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About iShares China Large-Cap ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.
Read more on FXI →
